In 2018, the World Health Organization (WHO) launched the Global Initiative for Childhood Cancer with the goal of reaching at least a 60% survival rate for children with cancer by 2030, while also reducing suffering. This initiative brings together doctors, nurses, other medical professionals, and governments, from around the world toward a shared goal of increasing the capacity of doctors to save lives and reduce suffering for children with cancer. If the goals of the program are achieved, approximately one million additional children with cancer will be saved in the next decade.
Candlelighters Childhood Cancer Foundation (CCCF) is a national nonprofit membership organization whose mission is to educate, support, serve and advocate for families of children with cancer, survivors of childhood cancer and the professionals who care for them.
The Pediatric Cancer Foundation, exists to raise money to fund pediatric cancer research. Their focus is to fund research which will lead to the elimination of pediatric cancer worldwide.
The National Children’s Cancer Society (NCCS) provides emotional, financial and educational support to children with cancer, their families and survivors.
Childhood Cancer International was founded in 1994, as an umbrella organization of childhood cancer grassroots and national parent organizations. Today, CCI is the largest patient support organization for childhood cancer. It is a global, parent-driven non-profit that represents more than 170 parent organizations, childhood cancer survivor associations, childhood cancer support groups, and cancer societies, in over 90 countries, across 5 continents.
The Latest Childhood Cancer News
National Cancer Institute: Making Transformative Advances against Childhood Cancer: A Conversation with Dr. Doug Hawkins
Doug Hawkins MD, a pediatric oncologist at Seattle Children’s Hospital is the chair of the Children’s Oncology Group (COG) discusses how the COG functions and how it is working to improve the care and curing many more children with cancer.
CAR-T Cell Therapy Demonstrates Similar Survival Across Socioeconomic Status in Children With Blood Cancer
Children with relapsed/refractory acute lymphoblastic leukemia living in poverty achieved similar outcomes to those from more advantaged households when treated with CAR-T cell therapy, according to a recent study. Previous research has demonstrated children with cancer who live in disadvantaged populations have worse survival outcomes compared to those in wealthier households.
Researchers Map Genomic Landscape of ALL
Dr. Stephen Hunger, Chief of the Division of Oncology, Director of the Center for Childhood Cancer Research at Children’s Hospital of Philadelphia and Medical Director of the Keira Grace Foundation is the co-senior author of an important new study that breaks new ground in our understanding of the many subtypes of acute lymphocytic leukemia (ALL). This new study will help us better understand new ways to treat children with leukemia and further improve survival.